Nucleic acid-based therapies have the potential to address numerous diseases that pose
significant challenges to more traditional methods. RNA-based therapies have emerged as …

Lung cancer is the leading cause of cancer-related death worldwide. Its high mortality is
partly due to chronic inflammation that accompanies the disease and stimulates cancer …

Background Recently, immunotherapy has become very hopeful for cancer therapy. Cancer
treatment through immunotherapy has excellent specificity and less toxicity than …

Aim In this review, we have attempted to provide the readers with an updated account of the
role of a family of proteins known as E3 ligases in different aspects of lung cancer …

Lung adenocarcinoma is regarded as the most common form of lung cancer, per the latest
epidemiological data. The combined efforts from chemotherapy and radiotherapy have done …

In recent years, the unique and diverse physicochemical properties of nanoparticles have
brought about their wide use in many fields; however, it is necessary to better understand …

Multiple myeloma (MM) is a hematological malignancy that remains incurable, primarily due
to the high likelihood of relapse or development of resistance to current treatments. To …

Non-Small Cell Lung Cancer (NSCLC) management remains a formidable challenge in the
field of oncology, representing a significant global health burden. However, recent years …

A series of eight novels'1, 3-diazetidin-2-ones have been proposed to assess their potential
activities. They are intended to examine antiproliferative effects through inhibition of …

Background NSCLC is a lethal cancer that is highly prevalent and accounts for 85% of cases
of lung cancer. Conventional cancer treatments, such as chemotherapy and radiation …